Paolo Carrega

3.3k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

Paolo Carrega is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Paolo Carrega has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 14 papers in Oncology and 7 papers in Surgery. Recurrent topics in Paolo Carrega's work include Immune Cell Function and Interaction (27 papers), T-cell and B-cell Immunology (17 papers) and Immunotherapy and Immune Responses (13 papers). Paolo Carrega is often cited by papers focused on Immune Cell Function and Interaction (27 papers), T-cell and B-cell Immunology (17 papers) and Immunotherapy and Immune Responses (13 papers). Paolo Carrega collaborates with scholars based in Italy, United States and Switzerland. Paolo Carrega's co-authors include Guido Ferlazzo, Maria Cristina Mingari, Lorenzo Moretta, Barbara Morandi, Irene Bonaccorsi, Roberta Costa, Giuseppe Forte, Giovanni Battista Ratto, Stefania Campana and Romana Conte and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Paolo Carrega

40 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade

2022 154 citations Carlo Genova, Chiara Dellepiane et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Carrega Italy	23	2.0k	922	300	241	151	40	2.5k
Christoph Bergmann Germany	22	1.6k 0.8×	953 1.0×	411 1.4×	165 0.7×	116 0.8×	54	2.3k
Jiacheng Bi China	18	1.4k 0.7×	976 1.1×	304 1.0×	113 0.5×	106 0.7×	30	1.9k
Alison M. Paterson United States	17	1.8k 0.9×	709 0.8×	220 0.7×	133 0.6×	114 0.8×	22	2.3k
Eugene Y. Chiang United States	21	1.9k 0.9×	1.4k 1.5×	494 1.6×	116 0.5×	127 0.8×	27	2.7k
Haoyu Sun China	20	1.6k 0.8×	1.1k 1.2×	385 1.3×	126 0.5×	189 1.3×	44	2.2k
Jai Rautela Australia	19	1.3k 0.6×	1.0k 1.1×	648 2.2×	86 0.4×	124 0.8×	31	2.1k
Elizabeth Tivol United States	11	2.8k 1.4×	1.5k 1.6×	423 1.4×	126 0.5×	168 1.1×	15	3.7k
Koho Iizuka United States	18	2.2k 1.1×	734 0.8×	291 1.0×	125 0.5×	403 2.7×	41	2.7k
Scott B. Lovitch United States	19	1.5k 0.7×	781 0.8×	554 1.8×	85 0.4×	276 1.8×	31	2.4k
Michele Ardolino Canada	17	2.0k 1.0×	1.4k 1.5×	481 1.6×	85 0.4×	159 1.1×	31	2.7k

Countries citing papers authored by Paolo Carrega

Since Specialization

Citations

This map shows the geographic impact of Paolo Carrega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Carrega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Carrega more than expected).

Fields of papers citing papers by Paolo Carrega

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Carrega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Carrega. The network helps show where Paolo Carrega may publish in the future.

Co-authorship network of co-authors of Paolo Carrega

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Carrega. A scholar is included among the top collaborators of Paolo Carrega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Carrega. Paolo Carrega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pezzino, Gaetana, Stefania Campana, Irene Bonaccorsi, et al.. (2024). EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses. ImmunoTargets and Therapy. Volume 13. 487–499. 1 indexed citations

Campana, Stefania, Claudia De Pasquale, Gaetana Pezzino, et al.. (2022). Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients. The Journal of Immunology. 209(4). 655–659. 6 indexed citations

Carrega, Paolo, Lodovica Zullo, Chiara Dellepiane, et al.. (2022). Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers. 14(20). 5046–5046. 14 indexed citations

Genova, Carlo, Chiara Dellepiane, Paolo Carrega, et al.. (2022). Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade. Frontiers in Immunology. 12. 799455–799455. 154 indexed citations breakdown →

Pasquale, Claudia De, Stefania Campana, Irene Bonaccorsi, Paolo Carrega, & Guido Ferlazzo. (2021). ILC in chronic inflammation, cancer and targeting with biologicals. Molecular Aspects of Medicine. 80. 100963–100963. 15 indexed citations

Pasquale, Claudia De, Alessandro Allegra, Fabrizio Loiacono, et al.. (2020). Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules. Blood Advances. 4(10). 2297–2307. 16 indexed citations

Cutroneo, Paola Maria, Valentina Isgrò, Valentina Ientile, et al.. (2020). Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database. British Journal of Clinical Pharmacology. 87(2). 527–541. 6 indexed citations

Bonaccorsi, Irene, Domenico Spinelli, Claudia Cantoni, et al.. (2019). Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands. Frontiers in Immunology. 10. 1503–1503. 33 indexed citations

Castriconi, Roberta, Paolo Carrega, Alessandra Dondero, et al.. (2018). Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues. Frontiers in Immunology. 9. 2324–2324. 99 indexed citations

10.

Genova, Carlo, Paolo Carrega, Gabriella Pietra, et al.. (2017). P3.02c-072 Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S1320–S1321. 1 indexed citations

11.

Carrega, Paolo, Stefania Campana, Irene Bonaccorsi, & Guido Ferlazzo. (2016). The Yin and Yang of Innate Lymphoid Cells in Cancer. Immunology Letters. 179. 29–35. 28 indexed citations

12.

Gandoglia, Ilaria, Federico Ivaldi, Paolo Carrega, et al.. (2016). In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma. Immunology Letters. 181. 109–115. 9 indexed citations

13.

Carrega, Paolo, Fabrizio Loiacono, Emma Di Carlo, et al.. (2015). NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nature Communications. 6(1). 8280–8280. 210 indexed citations

14.

Morandi, Barbara, Irene Bonaccorsi, M. Mesiti, et al.. (2013). Characterization of Human Afferent Lymph Dendritic Cells from Seroma Fluids. The Journal of Immunology. 191(9). 4858–4866. 16 indexed citations

15.

Laurent, Stefania, Paola Queirolo, Silvia Boero, et al.. (2013). The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production. Journal of Translational Medicine. 11(1). 108–108. 129 indexed citations

16.

Bellora, Francesca, Roberta Castriconi, Alessandra Dondero, et al.. (2013). Human NK cells and NK receptors. Immunology Letters. 161(2). 168–173. 50 indexed citations

17.

Carrega, Paolo & Guido Ferlazzo. (2012). Natural killer cell distribution and trafficking in human tissues. Frontiers in Immunology. 3. 347–347. 142 indexed citations

18.

Morandi, Barbara, Lorenzo Mortara, Paolo Carrega, et al.. (2009). NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs. International Immunology. 21(5). 599–606. 47 indexed citations

19.

Queirolo, Paola, Stefania Laurent, Monica Boitano, et al.. (2009). Targeting ctla-4 directly on melanoma cells: A possible novel perspective in the immunotherapy of cutaneous melanoma. Journal of Clinical Oncology. 27(15_suppl). e22138–e22138. 2 indexed citations

20.

Carrega, Paolo, Barbara Morandi, Roberta Costa, et al.. (2008). Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56^brightCD16⁻ cells and display an impaired capability to kill tumor cells. Cancer. 112(4). 863–875. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact